GlassScriptPhysician profile
Edith A Aguayo
NPI 1467546036
$2,448.81
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $337 · 2021: $421 · 2022: $301 · 2023: $559 · 2024: $65.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $445 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.84 |
| Education | $179.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $530.17 | 2019-2023 | Liletta, Orilissa, Lo Loestrin Fe |
| Therapeuticsmd, INC. | $282.96 | 2019-2022 | |
| Pfizer INC. | $273.17 | 2019-2023 | |
| Astellas Pharma US INC | $251.18 | 2023-2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $139.64 | 2019 | |
| Lupin INC. | $103.22 | 2019-2021 | |
| Terumo Medical Corporation | $99.40 | 2020 | |
| Mylan Pharmaceuticals INC. | $89.81 | 2019-2021 | |
| Exeltis, USA INC. | $85.32 | 2020-2023 | Slynd |
| Shield Therapeutics INC | $83.35 | 2023-2024 | Accrufer |
| Mayne Pharma Commercial LLC | $69.52 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.46 | 2019-2023 | |
| Amag Pharmaceuticals, INC. | $51.26 | 2019-2020 | |
| Evofem Biosciences, INC. | $50.83 | 2021 | |
| Meditrina | $40.48 | 2023-2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $33.64 | 2022 | |
| Minerva Surgical, INC | $27.22 | 2019-2021 | |
| Myovant Sciences INC. | $26.80 | 2021 | |
| Avion Pharmaceuticals | $25.01 | 2019-2023 | Balcoltra |
| Monaghan Medical Corporation | $21.62 | 2023 | Aeroeclipse |
| Axonics, INC. | $21.50 | 2024 | Axonics |
| Organon LLC | $20.61 | 2022 | |
| Merck Sharp & Dohme LLC | $17.30 | 2019 | |
| Exact Sciences Corporation | $14.78 | 2023 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $14.70 | 2021 | |
| Coloplast Corp | $13.07 | 2020 | |
| Novo Nordisk INC | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edith Aguayo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.